1. Dyslipidemias in children. Lilley JS, Linton MF, Fazio S (2012) Pediatr Ann 41(2): e1-7
    › Primary publication · 22299622 (PubMed)
  2. Dysfunctional high-density lipoprotein in patients on chronic hemodialysis. Yamamoto S, Yancey PG, Ikizler TA, Jerome WG, Kaseda R, Cox B, Bian A, Shintani A, Fogo AB, Linton MF, Fazio S, Kon V (2012) J Am Coll Cardiol 60(23): 2372-9
    › Primary publication · 23141484 (PubMed)
  3. Benzo[a]pyrene potentiates the pathogenesis of abdominal aortic aneurysms in apolipoprotein E knockout mice. Prins PA, Perati PR, Kon V, Guo Z, Ramesh A, Linton MF, Fazio S, Sampson UK (2012) Cell Physiol Biochem 29(1-2): 121-30
    › Primary publication · 22415081 (PubMed) · PMC3711770 (PubMed Central)
  4. Tie1 attenuation reduces murine atherosclerosis in a dose-dependent and shear stress-specific manner. Woo KV, Qu X, Babaev VR, Linton MF, Guzman RJ, Fazio S, Baldwin HS (2011) J Clin Invest 121(4): 1624-35
    › Primary publication · 21383501 (PubMed) · PMC3069759 (PubMed Central)
  5. Quantitative estimates of the variability of in vivo sonographic measurements of the mouse aorta for studies of abdominal aortic aneurysms and related arterial diseases. Sampson UK, Perati PR, Prins PA, Pham W, Liu Z, Harrell FE, Linton MF, Gore JC, Kon V, Fazio S (2011) J Ultrasound Med 30(6): 773-84
    › Primary publication · 21632991 (PubMed) · PMC3810347 (PubMed Central)
  6. Oral activated charcoal adsorbent (AST-120) ameliorates extent and instability of atherosclerosis accelerated by kidney disease in apolipoprotein E-deficient mice. Yamamoto S, Zuo Y, Ma J, Yancey PG, Hunley TE, Motojima M, Fogo AB, Linton MF, Fazio S, Ichikawa I, Kon V (2011) Nephrol Dial Transplant 26(8): 2491-7
    › Primary publication · 21245127 (PubMed) · PMC3203394 (PubMed Central)
  7. Novel domain interaction regulates secretion of proprotein convertase subtilisin/kexin type 9 (PCSK9) protein. Du F, Hui Y, Zhang M, Linton MF, Fazio S, Fan D (2011) J Biol Chem 286(50): 43054-61
    › Primary publication · 22027821 (PubMed) · PMC3234880 (PubMed Central)
  8. Macrophage polarization by angiotensin II-type 1 receptor aggravates renal injury-acceleration of atherosclerosis. Yamamoto S, Yancey PG, Zuo Y, Ma LJ, Kaseda R, Fogo AB, Ichikawa I, Linton MF, Fazio S, Kon V (2011) Arterioscler Thromb Vasc Biol 31(12): 2856-64
    › Primary publication · 21979434 (PubMed) · PMC3227118 (PubMed Central)
  9. Macrophage Mal1 deficiency suppresses atherosclerosis in low-density lipoprotein receptor-null mice by activating peroxisome proliferator-activated receptor-γ-regulated genes. Babaev VR, Runner RP, Fan D, Ding L, Zhang Y, Tao H, Erbay E, Görgün CZ, Fazio S, Hotamisligil GS, Linton MF (2011) Arterioscler Thromb Vasc Biol 31(6): 1283-90
    › Primary publication · 21474828 (PubMed) · PMC3135083 (PubMed Central)
  10. Low levels of high-density lipoprotein cholesterol due to lecithin:cholesterol acyltransferase mutations increase carotid atherosclerosis. Fazio S, Linton MF (2011) J Am Coll Cardiol 58(24): 2488-90
    › Primary publication · 22133848 (PubMed)